Ladenburg Thalmann Financial Services’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $118K | Sell |
1,834
-117
| -6% | -$7.53K | ﹤0.01% | 2888 |
|
|
2019
Q3 | $111K | Hold |
1,951
| – | – | ﹤0.01% | 2859 |
|
|
2019
Q2 | $114K | Sell |
1,951
-175
| -8% | -$10.2K | ﹤0.01% | 2875 |
|
|
2019
Q1 | $129K | Hold |
2,126
| – | – | ﹤0.01% | 2723 |
|
|
2018
Q4 | $116K | Buy |
2,126
+117
| +6% | +$6.38K | ﹤0.01% | 2653 |
|
|
2018
Q3 | $129K | Sell |
2,009
-85
| -4% | -$5.46K | ﹤0.01% | 2643 |
|
|
2018
Q2 | $119K | Hold |
2,094
| – | – | ﹤0.01% | 2649 |
|
|
2018
Q1 | $119K | Sell |
2,094
-675
| -24% | -$38.4K | ﹤0.01% | 2649 |
|
|
2017
Q4 | $164K | Sell |
2,769
-630
| -19% | -$37.3K | ﹤0.01% | 2357 |
|
|
2017
Q3 | $196K | Sell |
3,399
-1,365
| -29% | -$78.7K | ﹤0.01% | 2124 |
|
|
2017
Q2 | $281K | Sell |
4,764
-1,671
| -26% | -$98.6K | ﹤0.01% | 1782 |
|
|
2017
Q1 | $355K | Sell |
6,435
-2,149
| -25% | -$119K | ﹤0.01% | 1519 |
|
|
2016
Q4 | $451K | Sell |
8,584
-574
| -6% | -$30.2K | 0.01% | 1322 |
|
|
2016
Q3 | $526K | Buy |
9,158
+1,027
| +13% | +$59K | 0.01% | 1167 |
|
|
2016
Q2 | $477K | Buy |
8,131
+2,805
| +53% | +$165K | 0.01% | 1158 |
|
|
2016
Q1 | $306K | Buy |
5,326
+3,150
| +145% | +$181K | 0.01% | 1328 |
|
|
2015
Q4 | $142K | Hold |
2,176
| – | – | ﹤0.01% | 1812 |
|
|
2015
Q3 | $137K | Sell |
2,176
-926
| -30% | -$58.3K | ﹤0.01% | 1758 |
|
|
2015
Q2 | $219K | Sell |
3,102
-2,757
| -47% | -$195K | ﹤0.01% | 1550 |
|
|
2015
Q1 | $412K | Buy |
5,859
+2,303
| +65% | +$162K | 0.01% | 1145 |
|
|
2014
Q4 | $229K | Sell |
3,556
-158
| -4% | -$10.2K | 0.01% | 1330 |
|
|
2014
Q3 | $236K | Sell |
3,714
-1,319
| -26% | -$83.8K | 0.01% | 1133 |
|
|
2014
Q2 | $312K | Buy |
5,033
+2,605
| +107% | +$161K | 0.01% | 982 |
|
|
2014
Q1 | $142K | Buy |
2,428
+1,691
| +229% | +$98.9K | ﹤0.01% | 1315 |
|
|
2013
Q4 | $39K | Hold |
737
| – | – | ﹤0.01% | 2093 |
|
|
2013
Q3 | $35K | Buy |
737
+337
| +84% | +$16K | ﹤0.01% | 2076 |
|
|
2013
Q2 | $18K | Buy |
+400
| New | +$18K | ﹤0.01% | 2410 |
|